Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. (Q55067064)

16 June 2018

title

Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. (English)

1 reference

16 June 2018

1 reference

Haas M

1

1 reference

16 June 2018

publication date

1 June 1997

1 reference

16 June 2018

American Journal of Kidney Diseases

published in

1 reference

16 June 2018

volume

29

1 reference

16 June 2018

issue

6

1 reference

16 June 2018

page(s)

829-842

1 reference

16 June 2018

Idiopathic IgA mesangial nephropathy: histological features

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Proteinuria in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Development of hypertension in IgA nephropathy as a marker of a poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

IgA nephropathy: prognostic significance of proteinuria and histological alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

IgA nephropathy: morphologic predictors of progressive renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

IgA nephropathy histologically resembling focal-segmental glomerulosclerosis: a clinicopathologic study of 18 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Low incidence of IgA nephropathy in blacks

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Racial difference in the prevalence of IgA-associated nephropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Ultrastructural changes in IgA nephropathy in relation to histologic and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

IgA nephropathy in children: significance of glomerular basement membrane deposition of IgA.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Prognostic Indicators in Childhood IgA Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

The many masks of focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Alternate-day prednisone therapy in children with IgA-associated nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Double-blind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Moderately proteinuric IgA nephropathy: prognostic prediction of individual clinical courses and steroid therapy in progressive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Primary IgA nephropathy: prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy. Scientific Planning Committee of the IgA Nephropathy Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

Crescentic IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990456-X

1 reference

7 January 2021

10.1016/S0272-6386(97)90456-X

Identifiers

DOI

1 reference

16 June 2018

PubMed ID

9186068

1 reference

16 June 2018